ReviewCancers2022

Emetogenicity of Antibody-Drug Conjugates (ADCs) in Solid Tumors with a Focus on Trastuzumab Deruxtecan: Insights from an Italian Expert Panel.

Giampaolo Bianchini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.